2014
DOI: 10.1016/j.nbt.2013.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Enzyme catalysed production of sialylated human milk oligosaccharides and galactooligosaccharides by Trypanosoma cruzi trans-sialidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
30
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 39 publications
(30 citation statements)
references
References 45 publications
0
30
0
Order By: Relevance
“…Anion exchange chromatography for the purification of sialylated compounds prior to MALDI-TOF and NMR analysis was performed with an ÄKTA purifier 100 (GE Healthcare, Uppsala, Sweden) equipped with a SepharoseQ column (GE Healthcare, Uppsala, Sweden) as described previously [ 18 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Anion exchange chromatography for the purification of sialylated compounds prior to MALDI-TOF and NMR analysis was performed with an ÄKTA purifier 100 (GE Healthcare, Uppsala, Sweden) equipped with a SepharoseQ column (GE Healthcare, Uppsala, Sweden) as described previously [ 18 ].…”
Section: Methodsmentioning
confidence: 99%
“…rangeli (TrSA), which has a sequence identity of 70% to TcTS, has recently been engineered to primarily carry out trans-sialylation under certain reaction conditions [ 10 , 16 , 17 ]. Trans-sialidases are also of commercial interest as it has been demonstrated that both TcTS and mutants of TrSA can efficiently sialylate a variety of glycans, enabling the production of sialylated human milk oligosaccharides [ 10 , 16 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…Traditionally, when the production of SL has been performed at small scale, separation of lactose and SL has been achieved by anion exchange chromatography [5,4,3,2]. However, considering the economy of a large scale production process and the fact that anion exchange chromatography relies on the addition of buffers and eluents -which would then need to be removed before the SL can be considered for consumption -an alternative process for the efficient purification of SL from lactose is necessary for the addition of SL to infant formula to become a reality.…”
Section: Introductionmentioning
confidence: 99%
“…To upgrade the TcTS-mediated production of 3=-SL from lactose and a suitable, low-cost sialyl donor substrate, several protocols have been reported and patented. Attention has been paid especially to the use of the glycoproteins fetuin (30) and -casein-derived glycomacropeptide (31,32), both rich in (␣2-3)-linked sialic acid and available in relatively large amounts at relatively low cost, as sialyl donor substrates.…”
mentioning
confidence: 99%